News 25 Aug Canada Health Canada approves radiopaque bead for HCC, CRC liver metastases BTG International Canada Inc. announced it received approval for its drug-eluding device, the DC Bead LUMI, from Health Canada. The bead is the...
Update London, UK Institutional Decision to Adopt Y90 TARE with TheraSphere® as first-line treatment for HCC Based on experience with 1000 patients over 15 years, the largest single-centre, prospective centre cohort of patients with HCC treated with Y90 glass microspheres
Product DC Bead LUMI™ With DC Bead LUMI™, you are empowered to see the location of the beads during and after LUMI-TACE
Video Immunotherapy in combination with Cryoablation, TACE or SIRT BTG ECIO 2018 Symposium – ON DEMAND
Update London, UK BTG plc acquires Roxwood Medical London, UK, 5 October 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical (“Roxwood”), an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
News 12 Apr Indiana New procedure uses tiny beads to blast away liver cancer Treating cancer that began in the liver or has spread to the liver can often involve months of chemotherapy and painful radiation treatments. But...
News 06 May London, UK BTG snaps up cryogenic oncology specialist Galil for £58.3M BTG Group is buying a US company that develops medical devices which kill tumours by freezing them, as it looks to further boost its presence in...
Update London, UK Mirada Medical signs three-year software development agreement with BTG Mirada Medical Ltd, a global medical imaging software company, has signed a three-year master service agreement with BTG plc (LSE: BTG), a global specialist healthcare company. The agreement covers multiple software development projects to support BTG’s portfolio of interventional medicine products.
Update BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, have expanded their commitment to the Immuno-Oncology / Interventional Oncology research grant programme, by announcing a second round of funding available to investigators.
News 07 Jan US and Canada Cutting Edge Treatment Improves Prospects For Liver Cancer Patients RESEARCH ADVANCES In October, iconic buildings throughout the United Kingdom were bathed in pink light. NFL players wore pink on their shoes during...
Events 01 Nov 18 Synergy: A Multidisciplanary Approach to Interventional Oncology Miami Beach, FL, United States
@BTGIO" src="/getattachment/Data/Announcement/Twitter-No2/DEBIRI-workshop-Jan-2018-2.PNG.aspx?lang=en-GB&width;=1267&height;=899&ext;=.png"> @BTGIO
@BTGIO" src="/getattachment/Data/Announcement/Twitter/DEBIRI-workshop-Jan-2018.PNG.aspx?lang=en-GB&width;=1333&height;=1010&ext;=.png"> @BTGIO
Video DC Bead LUMI™ Building on the established clinical performance of DC Bead®, DC Bead LUMI™ provides real-time visible confirmation of bead location during embolisation.
@BTGIO" src="/getattachment/Data/Announcement/BTGIO/World-Cancer-Day.jpg.aspx?lang=en-GB&width;=600&height;=421&ext;=.jpg"> @BTGIO
Events 31 May-02 Jun 18 CAIR - Canadian Association for Interventional Radiology Calgary, AB, United States
Video TheraSphere® TheraSphere® yttrium-90 glass microspheres deliver a targeted radiation dose to the tumour whilst minimising exposure to healthy tissue with mild to...
Events 22-26 Sep 18 CIRSE – Cardiovascular and Interventional Radiology Society of Europe Lisbon, Portugal